
|Articles|March 1, 2018
- Pharmaceutical Executive-03-01-2018
- Volume 38
- Issue 3
Pharmaceutical Executive, March 2018 Issue (PDF)
Click the title above to open the Pharmaceutical Executive March 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 8 years ago
Pharma: Meet Your New Neighborsabout 8 years ago
Risk Sharing, Italian Styleabout 8 years ago
The Quest to Measure Upover 8 years ago
Full Disclosure Demanded for Pharma Industryover 8 years ago
Setting the Standard: William Soliman, ACMAover 8 years ago
The Law of Unintended Consequencesover 8 years ago
Pricing Turning Point: The Case for Innovating Pharma’s Modelover 8 years ago
Showdown Nears on Europe Research Incentivesover 8 years ago
The Personalized Genetic Profile: It’s Time to Alignover 8 years ago
Country Report: IndiaAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
How New Technologies Are Impacting the Vaccine Market
2
Deepening Ties: Why China is Becoming Big Pharma's Most Essential R&D Partner
3
Pharmaceutical Executive Daily: Kardigan Sets Terms for $350 Million IPO
4
Zepzelca Fails to Meet Main Goal of Phase III Lagoon Trial in Second-Line Small Cell Lung Cancer
5




